| Lee Alison Voi, CNM,MSN | |
|
4400 Broadway St, Suite 302, Kansas City, MO 64111-3498 | |
| (816) 931-9344 | |
| (816) 931-4168 |
| Full Name | Lee Alison Voi |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 4400 Broadway St, Kansas City, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508802463 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 113711 (Missouri) | Primary |
| Entity Name | Ferns, Matile, Perryman & Moore, M.d.'s, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063457141 PECOS PAC ID: 9830137041 Enrollment ID: O20050419000801 |
News Archive
Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today that the Company received a milestone payment from Pfizer Inc. The amount of the payment was not disclosed. The payment was triggered by the initiation of human clinical trials of a novel monoclonal antibody therapeutic that was optimized using Xencor technologies under a March 2009 technology license agreement.
A new study by scientists from the University of California San Diego, USA and Maynooth University, Ireland and published on the preprint server bioRxiv* in June 2020 reports preliminary results showing that the spike protein of the SARS-CoV-2, as well as its glycan coat, has "hitherto unseen functional and structural" properties. These may be useful in designing novel therapeutics to target this molecule.
Researchers at the National Institutes of Health have discovered a second gene that causes melorheostosis, a rare group of conditions involving an often painful and disfiguring overgrowth of bone tissue.
Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer.
Instead of surgically removing a sample of skin, sending it to a lab and waiting several days for results, your dermatologist takes pictures of a suspicious-looking lesion and quickly produces a detailed, microscopic image of the skin.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lee Alison Voi, CNM,MSN 4400 Broadway St, Suite 302, Kansas City, MO 64111-3498 Ph: (816) 931-9344 | Lee Alison Voi, CNM,MSN 4400 Broadway St, Suite 302, Kansas City, MO 64111-3498 Ph: (816) 931-9344 |
News Archive
Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today that the Company received a milestone payment from Pfizer Inc. The amount of the payment was not disclosed. The payment was triggered by the initiation of human clinical trials of a novel monoclonal antibody therapeutic that was optimized using Xencor technologies under a March 2009 technology license agreement.
A new study by scientists from the University of California San Diego, USA and Maynooth University, Ireland and published on the preprint server bioRxiv* in June 2020 reports preliminary results showing that the spike protein of the SARS-CoV-2, as well as its glycan coat, has "hitherto unseen functional and structural" properties. These may be useful in designing novel therapeutics to target this molecule.
Researchers at the National Institutes of Health have discovered a second gene that causes melorheostosis, a rare group of conditions involving an often painful and disfiguring overgrowth of bone tissue.
Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer.
Instead of surgically removing a sample of skin, sending it to a lab and waiting several days for results, your dermatologist takes pictures of a suspicious-looking lesion and quickly produces a detailed, microscopic image of the skin.
› Verified 8 days ago
Samantha Collinson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 7900 Lees Summit Rd, Kansas City, MO 64139 Phone: 816-404-8243 | |
Sarah Jean Gill, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-4020 | |
Julie L Talley, APRN CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 825 Euclid Ave, Kansas City, MO 64124 Phone: 816-474-4920 Fax: 816-474-4914 | |
Mrs. Kathryn Johnston, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 8600 Ne 82nd St, Kansas City, MO 64158 Phone: 816-741-9122 Fax: 816-741-9655 | |
Laura Laney, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2211 Charlotte St, Kansas City, MO 64108 Phone: 816-404-4966 | |
Ms. Katherine J Lorand, APRN CNM MPH Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 6400 Prospect Ave, Suite 598, Kansas City, MO 64132 Phone: 816-444-6888 Fax: 816-444-1375 |